The Singles takes on OpenAI, Tylenol & Stiller Soda

In this episode, we dive deep into the latest marketing trends and campaigns we start by discussing OpenAI's new brand campaign, evaluating its impact and effectiveness. The conversation transitions to the growing competition in the AI space between ChatGPT and Claude, highlighting user adoption and brand health metrics. The trio also explores the recent controversies faced by Tylenol and how brand trust plays a crucial role in weathering PR storms. Lastly, they touch on Ben Stiller's foray into the healthier soda market with Stiller Soda and analyze the potential market dynamics. The episode is packed with insightful data and expert opinions, offering a comprehensive look at current marketing strategies and brand health management.

02:30 OpenAI's New Brand Campaign

03:23 AI Competitors and Market Penetration

08:17 Emotional Advertising and Brand Loyalty

13:25 Tylenol's PR Crisis and Brand Trust

21:02 Ben Stiller's Entry into the Soft Drink Market

29:16 Year-End Reflections

With thanks to Tracksuit

That’s What I Call Marketing is where marketers come for real conversations about brand, B2B, creativity, effectiveness and the future of the profession.

Hosted by Conor Byrne, the show features conversations with CMOs, marketing leaders, agency leaders, authors, thinkers and practitioners about what good marketing looks like in practice.

Listen, follow and find more episodes at: https://www.thatswhaticallmarketing.com

Connect with Conor on LinkedIn: https://www.linkedin.com/in/conorbyrneirl/

If you enjoy the show, please follow, subscribe and leave a review. It helps more marketers find the conversations.

Hosted on Acast. See acast.com/privacy for more information.